3D Systems (DDD) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Apr, 2026Executive summary
Supplement updates voting recommendations, by-law amendment, and corrects share count for the 2026 Annual Meeting.
ISS recommends voting for all director nominees, executive compensation, auditor ratification, and share increase, but against the Equity Plan Proposal.
Board disagrees with ISS on the Equity Plan Proposal, emphasizing its importance for talent retention and cost restructuring.
Correction issued for the number of shares outstanding as of the record date: 146,057,215 shares.
Ongoing shareholder engagement and outreach efforts are highlighted.
Voting matters and shareholder proposals
ISS recommends voting for all nine director nominees, executive compensation, auditor ratification, and share increase.
ISS recommends voting against the Equity Plan Proposal due to concerns over plan cost, burn rate, share recycling, and vesting discretion.
Board urges shareholders to vote for all proposals, especially the Equity Plan Proposal.
Board of directors and corporate governance
Board adopted amended and restated by-laws to clarify voting standards, aligning with Delaware law; no substantive change to voting standards.
Latest events from 3D Systems
- Revenue fell 8% YoY, net loss widened, but cost actions and asset sale strengthened liquidity.DDD
Q1 20259 Jul 2026 - Sequential revenue growth and margin gains offset year-over-year declines; outlook remains positive.DDD
Q2 20248 Jul 2026 - 2024 revenue hit $440M; cost cuts and Geomagic sale target break-even EBITDA by Q4 2025.DDD
Q4 20248 Jul 2026 - Plans to raise up to $100M for acquisitions and corporate needs, with broad risk disclosures.DDD
Registration filing22 May 2026 - Revenue up 11%, Healthcare surged 21%, and EBITDA turned positive on higher gross margin.DDD
Q1 202612 May 2026 - Proxy covers director elections, compensation, auditor, share increase, and incentive plan changes.DDD
Proxy filing8 Apr 2026 - Proxy seeks approval for board elections, compensation, auditor, share increase, and incentive plan.DDD
Proxy filing26 Mar 2026 - Q4 2025 saw 16% sequential growth, margin gains, and $55M in cost savings, led by key segments.DDD
Q4 20259 Mar 2026 - FDA-approved 3D printed dentures and aerospace growth position the business for major expansion.DDD
28th Annual Needham Growth Conference Virtual13 Jan 2026